Lawrence Waldman - 15 May 2025 Form 4 Insider Report for Apyx Medical Corp (APYX)

Role: Director
Signature: /s/ Lawrence J. Waldman
Issuer symbol: APYX
Transactions as of: 15 May 2025
Net transactions value: $0
Form type: 4
Filing time: 19 May 2025, 16:31:10 UTC
Previous filing: 17 Jan 2025
Next filing: 12 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Waldman Lawrence	Director	C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER	/s/ Lawrence J. Waldman	19 May 2025	0001516592

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APYX	Stock Option (Option to Buy)	Award	$0	+30,000		$0.000000	30,000	15 May 2025	Common Stock	30,000	$1.48	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.